IRF9 and myelodysplastic syndrome: Thereby, 6 key candidates, IRF9, PLA2G4A, MLKL, BAX, JAK2, and STAT3, were selected as diagnostic markers for MDS based on the scRNA-seq data and bulk RNA-freq data (Fig. 7E).